Hedge Fund and Insider Trading News: Steven Cohen, Starboard Value, Zendesk Inc (ZEN), CTI BioPharma Corp (CTIC), and More

Zendesk Inc (ZEN) Insider Adrian Mcdermott Sells 50,000 Shares of Stock (WeekHerald.com)
Zendesk Inc (NYSE:ZEN) insider Adrian Mcdermott sold 50,000 shares of the business’s stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $39.08, for a total transaction of $1,954,000.00. Following the completion of the transaction, the insider now owns 1,614,969 shares of the company’s stock, valued at $63,112,988.52. The sale was disclosed in a legal filing with the SEC.

Insider Buying: CTI BioPharma Corp (CTIC) Insider Acquires 6,333,333 Shares of Stock (TrueBlueTribune.com)
CTI BioPharma Corp (NASDAQ:CTIC) insider Biotechnology Value Fund L.P. purchased 6,333,333 shares of the company’s stock in a transaction on Friday, February 9th. The shares were purchased at an average price of $3.00 per share, with a total value of $18,999,999.00. The purchase was disclosed in a filing with the Securities & Exchange Commission.

Insider Buying: Babcock & Wilcox Enterprises Inc (BW) Major Shareholder Acquires 41,456 Shares of Stock (DispatchTribunal.com)
Babcock & Wilcox Enterprises Inc (NYSE:BW) major shareholder Steel Partners Holdings L.P. bought 41,456 shares of the company’s stock in a transaction that occurred on Monday, February 12th. The stock was bought at an average cost of $5.90 per share, for a total transaction of $244,590.40. The purchase was disclosed in a document filed with the Securities & Exchange Commission.

Insider Buying: Unifi, Inc. (UFI) Director Purchases 13,179 Shares of Stock (RegistrarJournal.com)
Unifi, Inc. (NYSE:UFI) Director Robert J. Bishop bought 13,179 shares of the stock in a transaction dated Friday, February 9th. The stock was bought at an average price of $35.13 per share, with a total value of $462,978.27. Following the purchase, the director now owns 10,288 shares of the company’s stock, valued at approximately $361,417.44. The transaction was disclosed in a filing with the Securities & Exchange Commission.

Gemphire Therapeutics Inc (GEMP) Insider Steven R. Ph.D. Gullans Buys 71,429 Shares of Stock (WeekHerald.com)
Gemphire Therapeutics Inc (NASDAQ:GEMP) insider Steven R. Ph.D. Gullans acquired 71,429 shares of Gemphire Therapeutics stock in a transaction on Thursday, February 8th. The stock was purchased at an average cost of $7.00 per share, with a total value of $500,003.00. The purchase was disclosed in a document filed with the SEC.